Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woggon

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Archiv Fur Psychiatrie Und Nervenkrankheiten|July 4, 1979
[Interrater reliability of diagnosis, AMP syndromes and AMP symptoms (author's transl)]U Baumann, B Woggon
International Pharmacopsychiatry|January 1, 1978
Double-blind comparison of bromperidol and perphenazineB Woggon, J Angst
Arzneimittel-Forschung|January 1, 1976
[Activity profile of carpipramine. Results of an open trial and a double-blind trial versus doxepin]B Woggon, J Angst
International Pharmacopsychiatry|January 1, 1979
[Construction of second order AMP scales: "manic depressives" and "schizophrenic syndrome"]B Woggon, A Dittrich
Pharmacopsychiatria|November 1, 1983
Multimethodological approach in psychiatric predictor researchB Woggon, U Baumann
Pharmacopsychiatry|January 27, 1998
A case of serotonin syndrome caused by venlafaxine and lithiumG Mekler, B Woggon
Die Nahrung|January 1, 1978
[Contamination by lead and cadmium during smoke drying of cereals]H Woggon, Z Malkus
Die Nahrung|January 1, 1976
[Lead and cadmium content of baby food and their nutritional hygienic-toxicological significance]H Woggon, D Jehle
International Pharmacopsychiatry|January 1, 1977
Open trial and double-blind clinical trial of the antidepressant Ro 8-1998 in comparison with imipramineB Woggon, J Angst
Arzneimittel-Forschung|February 1, 1975
[Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]J Angst, B Woggon
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Archiv Fur Psychiatrie Und Nervenkrankheiten|July 4, 1979
[Interrater reliability of diagnosis, AMP syndromes and AMP symptoms (author's transl)]U Baumann, B Woggon
International Pharmacopsychiatry|January 1, 1978
Double-blind comparison of bromperidol and perphenazineB Woggon, J Angst
Arzneimittel-Forschung|January 1, 1976
[Activity profile of carpipramine. Results of an open trial and a double-blind trial versus doxepin]B Woggon, J Angst
International Pharmacopsychiatry|January 1, 1979
[Construction of second order AMP scales: "manic depressives" and "schizophrenic syndrome"]B Woggon, A Dittrich
Pharmacopsychiatria|November 1, 1983
Multimethodological approach in psychiatric predictor researchB Woggon, U Baumann
Pharmacopsychiatry|January 27, 1998
A case of serotonin syndrome caused by venlafaxine and lithiumG Mekler, B Woggon
Die Nahrung|January 1, 1978
[Contamination by lead and cadmium during smoke drying of cereals]H Woggon, Z Malkus
Die Nahrung|January 1, 1976
[Lead and cadmium content of baby food and their nutritional hygienic-toxicological significance]H Woggon, D Jehle
International Pharmacopsychiatry|January 1, 1977
Open trial and double-blind clinical trial of the antidepressant Ro 8-1998 in comparison with imipramineB Woggon, J Angst
Arzneimittel-Forschung|February 1, 1975
[Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]J Angst, B Woggon
Pageof 17